News

HealthRX enhances online platform to offer doctor-prescribed GLP-1 medications like Ozempic® and Zepbound® for adults seeking ...
The update provides streamlined access to GLP-1 medications such as Ozempic®, Zepbound®, and compounded alternatives-subject to eligibility criteria and clinical discretion. The HealthRX platform is ...
Scholar Rock's Apitegromab excels in Phase 2 trials, aiding muscle preservation with Tirzepatide. Click here to read why I think SRRK stock could be a Buy.
IQVIA figures on prescriptions for Zepbound and Wegovy, reported by Reuters, suggest that there were nearly 339,000 scrips for Lilly's product in the week ending 18th April, overtaking Novo ...
Lilly recently revised its revenue forecast for 2024 after seeing weaker-than-expected growth for Zepbound and diabetes brand Mounjaro in the last three months of the year, although, they still ...
Ro's Body Program is a comprehensive weight loss solution that offers personalized plans utilizing a glucagon-like peptide-1 (GLP-1) receptor agonist medications such as Ozempic, Wegovy and Zepbound.
Get the latest news and real-time alerts from Novo Nordisk A/S (NVO) stock at Seeking Alpha.